A method for reducing misclassification in the extended Glasgow Outcome Score

Journal of Neurotrauma

Volumn 27, Issue 5, 2010, Pages 843-852

  Lu, Juan ^a   Marmarou, Anthony ^a   Lapane, Kate ^b   Turf, Elizabeth ^b   Wilson, Lindsay ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Clinical trial; Extended Glasgow Outcome Scale; Inter rater variation; Misclassification; Traumatic brain injury

Indexed keywords

ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; ERROR; EXTENDED GLASGOW OUTCOME SCALE; GLASGOW OUTCOME SCALE; HUMAN; INTERMETHOD COMPARISON; LEISURE; OBSERVER VARIATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL BEHAVIOR; STRUCTURED INTERVIEW; TRAUMATIC BRAIN INJURY; WORK CAPACITY;

BRAIN; BRAIN INJURIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; GLASGOW OUTCOME SCALE; HUMANS; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TEACHING;

EID: 77952980749     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1293     Document Type: Article

References (19)

1. Brooks, D.N., Hosie, J., Bond, M.R., Jennett, B., and Aughton, M. (1986). Cognitive sequelae of severe head injury in relation to the Glasgow Outcome Scale. J. Neurol. Neurosurg. Psychiatry 49, 549-553.
2. Choi, S.C., Clifton, G.L., Marmarou, A., and Miller, E.R. (2002). Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma. J. Neurotrauma 19, 17-22.
3. Clifton, G.L., Choi, S.C., Miller, E.R., Levin, H.S., Smith, K.R., Jr., Muizelaar, J.P., Wagner, F.C., Jr., Marion, D.W., and Luerssen, T.G. (2001). Intercenter variance in clinical trials of head trauma-experience of the National Acute Brain Injury Study: Hypothermia. J. Neurosurg. 95, 751-755.
4. Cohen, J. (1968). Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol. Bull. 70, 213-220.
5. Jennett, B., and Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet 1, 480-484.
6. Jennett, B., Snoek, J., Bond, M.R., and Brooks, N. (1981). Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J. Neurol. Neurosurg. Psychiatry 44, 285-293.
7. Landis, J.R., and Koch, G.G. (1977). An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33, 363-374.
8. Lu, J., Murray, G.D., Steyerberg, E.W., Butcher, I., McHugh, G.S., Lingsma, H., Mushkudiani, N., Choi, S., Maas, A.I., and Marmarou, A. (2008). Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials. J. Neurotrauma 25, 641-651.
9. Maas, A.I., Braakman, R., Schouten, H.J., Minderhoud, J.M., and van Zomeren, A.H. (1983). Agreement between physicians on assessment of outcome following severe head injury. J. Neurosurg. 58, 321-325.
10. Maas, A.I., Murray, G., Henney, H., 3rd, Kassem, N., Legrand, V., Mangelus, M., Muizelaar, J.P., Stocchetti, N., Knoller, N., and Pharmos TBI investigators. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 5, 38-45.
11. Maas, A.I., Steyerberg, E.W., Murray, G.D., Bullock, R., Baethmann, A., Marshall, L.F., and Teasdale, G.M. (1999). Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 44, 1286-1298.
12. Marmarou, A., Guy, M., Murphey, L., Roy, F., Layani, L., Combal, J.P., Marquer, C., and American Brain Injury Consortium. (2005). A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury. J. Neurotrauma 22, 1444-1455.
13. Marmarou, A. (2001). Head Trauma: Basic, Preclinical, Clinical Direction, 1st ed. Wiley: New York, p. 15.
14. Marmarou, A., Nichols, J., Burgess, J., Newell, D., Troha, J., Burnham, D., and Pitts, L. (1999). Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebocontrolled trial. American Brain Injury Consortium Study Group. J. Neurotrauma 16, 431-444.
15. Narayan, R.K., Michel, M.E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M.B., Bullock, M.R., Choi, S.C., Clifton, G.L., Contant, C.F., Coplin, W.M., Dietrich, W.D., Ghajar, J., Grady, S.M., Grossman, R.G., Hall, E.D., Heetderks, W., Hovda, D.A., Jallo, J., Katz, R.L., Knoller, N., Kochanek, P.M., Maas, A.I., Majde, J., Marion, D.W., Marmarou, A., Marshall, L.F., McIntosh, T.K., Miller, E., Mohberg, N., Muizelaar, J.P., Pitts, L.H., Quinn, P., Riesenfeld, G., Robertson, C.S., Strauss, K.I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M.D., Weinrich, M., Whyte, J., Wilberger, J., Young, A.B., and Yurkewicz, L. (2002). Clinical trials in head injury. J. Neurotrauma 19, 503-557.
16. Pettigrew, L.E., Wilson, J.T., and Teasdale, G.M. (1998). Assessing disability after head injury: improved use of the Glasgow Outcome Scale. J. Neurosurg. 89, 939-943.
17. Teasdale, G.M., Pettigrew, L.E., Wilson, J.T., Murray, G., and Jennett, B. (1998). Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J. Neurotrauma 15, 587-597.
18. Wilson, J.T., Pettigrew, L.E., and Teasdale, G.M. (1998). Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J. Neurotrauma 15, 573-585.
19. Wilson, J.T., Slieker, F.J., Legrand, V., Murray, G., Stocchetti, N., and Maas, A.I. (2007). Observer variation in the assessment of outcome in traumatic brain injury: experience from a multicenter, international randomized clinical trial. Neurosurgery 61, 123-128; discussion 128-129.